C3i Center

C3i Center Contract Manufacturing & Development (CDMO) Profile

C3i is a fully integrated CDMO in CGT manufacturing. Offer flexible model to accomodate needs of early cell and gene therapy companies with phase appropriate Qc testing. We manufacture from process development to commercial. C3i is the 1st and only CDMO in Canada with a license to manufacture commercial cell therapies. C3i expects to obtain commercial authorization for the EU and FDA market in 2025.

CDMO Services:
Cell & Gene Therapy Drug Substance Manufacturing (API); Drug Product Formulation (FDF); Research & Development; Clinical Trials materials and logistics; Regulatory Services; Analytical Development Cartridges; Liquids Analytical Development; Cell Line Development; Formulation Development; ICH Stability Testing; Process Development Live Biotherapeutic Products

Year Founded: 1992

Head Office: Montréal, Canada

Number of Facilities: 1

Facility locations: North America

Website: Visit the C3i Center website

Linkedin: Connect on Linkedin

Current Capacity: C3i can onboard additional clients that are looking for process development to manufacturing of marketed cell therapies.